About Dehydrogenase/reductase SDR family member 13
Dehydrogenase/reductase SDR family member 13 (DHRS13) is a protein
from Homo sapiens identified by UniProt accession
Q6UX07, 377 residues long.
MolForge cross-references it against 0 known binders and
23 disease associations.
Target properties
| Protein name | Dehydrogenase/reductase SDR family member 13 |
| UniProt accession | Q6UX07 |
| Gene | DHRS13 |
| Organism | Homo sapiens |
| Length | 377 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (23)
Diseases linked to this target (Open Targets).
- HbA1c measurement · score 0.18
- erythrocyte count · score 0.09
- smoking status measurement · score 0.08
- smoking initiation · score 0.08
- cigarettes per day measurement · score 0.08
- language measurement · score 0.06
- functional brain measurement · score 0.06
- cortical thickness · score 0.06
- myeloid white cell count · score 0.05
- mathematical ability · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UX07-F1 | alphafold | PREDICTED | 82.84 | — |
Amino-acid sequence (377 residues)
MEALLLGAGL LLGAYVLVYY NLVKAPPCGG MGNLRGRTAV VTGANSGIGK MTALELARRG ARVVLACRSQ ERGEAAAFDL RQESGNNEVI FMALDLASLA SVRAFATAFL SSEPRLDILI HNAGISSCGR TREAFNLLLR VNHIGPFLLT HLLLPCLKAC APSRVVVVAS AAHCRGRLDF KRLDRPVVGW RQELRAYADT KLANVLFARE LANQLEATGV TCYAAHPGPV NSELFLRHVP GWLRPLLRPL AWLVLRAPRG GAQTPLYCAL QEGIEPLSGR YFANCHVEEV PPAARDDRAA HRLWEASKRL AGLGPGEDAE PDEDPQSEDS EAPSSLSTPH PEEPTVSQPY PSPQSSPDLS KMTHRIQAKV EPEIQLS
Explore Dehydrogenase/reductase SDR family member 13 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets